Evidence map›Paper›PMID 32887663›Full record

SynthesisParasites & vectors2020

Health sequelae of human cryptosporidiosis in industrialised countries: a systematic review.

Bethan L Carter, Rachel M Chalmers, Angharad P Davies

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Monitoring of cryptosporidiosis: a shift in circulatingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. A largeEpidemiology and infection · 2025
    Article
  3. Article
  4. Genetic diversity ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  5. Current research in parasitology & vector-borne diseases · 2025
    Article
  6. Review
  7. Nanoparticle Lysis ofMethods and protocols · 2024
    Article
  8. Article
  9. Article
  10. Outbreak of Diarrhea Caused by a NovelOpen forum infectious diseases · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. An Update on ZoonoticAnimals : an open access journal from MDPI · 2021
    Review
  19. Article
  20. Opportunities and Challenges in Developing aACS infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Bethan L CarterSwansea University Medical School, Swansea University, Singleton Park, Swansea, UK.
Rachel M ChalmersSwansea University Medical School, Swansea University, Singleton Park, Swansea, UK.
Angharad P DaviesSwansea University Medical School, Swansea University, Singleton Park, Swansea, UK. angharad.p.davies@swansea.ac.uk.
Swansea University · GBPublic Health Wales · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCryptosporidium is a protozoan parasite which is a common cause of gastroenteritis worldwide. In developing countries, it is one of the most important causes of moderate to severe diarrhoea in young children; in industrialised countries it is a cause of outbreaks of gastroenteritis associated with drinking water, swimming pools and other environmental sources and a particular concern in certain immunocompromised patient groups, where it can cause severe disease. However, over recent years, longer-term sequelae of infection have been recognised and a number of studies have been published on this topic. The purpose of this systematic review was to examine the literature in order to better understand the medium- to long-term impact of cryptosporidiosis.

methodsThis was a systematic review of studies in PubMed, ProQuest and Web of Science databases, with no limitations on publication year or language. Studies from any country were included in qualitative synthesis, but only those in industrialised countries were included in quantitative analysis.

resultsFifteen studies were identified for qualitative analysis which included 3670 Cryptosporidium cases; eight studies conducted in Europe between 2004-2019 were suitable for quantitative analysis, including five case-control studies. The most common reported long-term sequelae were diarrhoea (25%), abdominal pain (25%), nausea (24%), fatigue (24%) and headache (21%). Overall, long-term sequelae were more prevalent following infection with Cryptosporidium hominis, with only weight loss and blood in stool being more prevalent following infection with Cryptosporidium parvum. Analysis of the case-control studies found that individuals were 6 times more likely to report chronic diarrhoea and weight loss up to 28 months after a Cryptosporidium infection than were controls. Long-term abdominal pain, loss of appetite, fatigue, vomiting, joint pain, headache and eye pain were also between 2-3 times more likely following a Cryptosporidium infection.

conclusionsThis is the first systematic review of the long-term sequelae of cryptosporidiosis. A better understanding of long-term outcomes of cryptosporidiosis is valuable to inform the expectations of clinicians and their patients, and public health policy-makers regarding the control and prevention of this infection. Systematic review registration PROSPERO Registration number CRD42019141311.

Indexed as

CryptosporidiosisCryptosporidiumCryptosporidium parvumDeveloped CountriesDiarrheaDisease OutbreaksEuropeFatigueGastroenteritisHumansNauseaPrevalenceCryptosporidiosisCryptosporidium hominisCryptosporidium parvumSequelae

Identifiers

PMID32887663
PMCPMC7650228
OpenAlexW3083032280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.